acrolein has been researched along with Diabetes Mellitus, Type 2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barre, DE; Mizier-Barre, KA | 1 |
| Gorska-Ponikowska, M; Kostrzewa, T; Kuban-Jankowska, A; Przychodzen, P | 1 |
| Attanasio, R; Feroe, AG; Scinicariello, F | 1 |
| Guo, FJ; Li, ML; Meng, Y; Xu, YC; Zhang, W | 1 |
| Fan, MS; Huang, CG; Li, ZX; Sun, ZL; Tang, YH | 1 |
| Guo, X; Li, J; Liu, T; Qin, L; Sun, W; Wang, L; Wu, L; Xu, T | 1 |
| Daimon, M; Hirata, A; Igarashi, M; Kameda, W; Kato, T; Ohnuma, H; Oizumi, T; Saitoh, T; Sugiyama, K; Yamaguchi, H | 1 |
1 review(s) available for acrolein and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus.
Topics: Acrolein; Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Inflammation; Obesity, Abdominal; Polypharmacy | 2020 |
6 other study(ies) available for acrolein and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Curcumin and Cinnamaldehyde as PTP1B Inhibitors With Antidiabetic and Anticancer Potential.
Topics: Acrolein; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Curcumin; Diabetes Mellitus, Type 2; Drug Screening Assays, Antitumor; Female; Humans; Hypoglycemic Agents; MCF-7 Cells; Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2019 |
Acrolein metabolites, diabetes and insulin resistance.
Topics: Acetylcysteine; Acrolein; Adult; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Insulin Resistance; Male; Nutrition Surveys | 2016 |
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.
Topics: Acrolein; Animals; Berberine; Blotting, Western; Body Weight; Diabetes Mellitus, Type 2; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Rats; Rats, Wistar; Retinol-Binding Proteins, Plasma | 2008 |
Anti-diabetic effects of TongGuanWan, a Chinese traditional herbal formula, in C57BL/KsJ-db/db mice.
Topics: Acrolein; Administration, Oral; Animals; Berberine; Blood Glucose; Body Weight; Cholesterol, HDL; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glucose Intolerance; Glycated Hemoglobin; Hypoglycemic Agents; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Phytotherapy; Rosiglitazone; Saponins; Thiazolidinediones; Triglycerides; Xanthones | 2012 |
Antihyperglycemic and antihyperlipidemic action of cinnamaldehyde in C57BLKS/J db/db mice.
Topics: Acrolein; Adiponectin; Animals; Cinnamomum zeylanicum; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Mice; Plant Extracts; Tumor Necrosis Factor-alpha | 2012 |
Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes.
Topics: Acrolein; Adult; Arginine; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Lysine; Male; Middle Aged; Norleucine; Pyrroles; Smoking | 2003 |